Home
Language
English
Türkçe
Bahasa Indonesia
About
Privacy Policy
Terms of Service
Pricing
Sign In
Download All
Share
TwoFour Insight
@TwoFourInsight
Regulatory and policy intelligence on US & India's life science market and industry. Clear Vision For The Life Sciences Industry - tweets ≠ endorsement
Pitt | WashDC | New Delhi
Joined January 2014
415
Following
405
Followers
11.6K
Posts
TwoFour Insight
@TwoFourInsight
about 10 years ago
Cost of
#Pharma
Business Set to Increase in
#India
- User Fees Rising Six-Fold | TwoFour Insight Group https://t.co/VxRC85P83y
TwoFour Insight
@TwoFourInsight
about 10 years ago
Cost of
#Pharma
Business Set to Increase in
#India
- User Fees Rising Six-Fold | TwoFour Insight Group https://t.co/mSgX6Uhx62
TwoFour Insight
@TwoFourInsight
about 10 years ago
Cost of
#Pharma
Business Set to Increase in
#India
- User Fees Rising Six-Fold | TwoFour Insight Group https://t.co/SZ9IhuwzUX
TwoFour Insight
@TwoFourInsight
about 10 years ago
Sanofi Obtains Indian Patent for Azabicycloalkane Derivatives - TwoFour Insight Group https://t.co/XxL9R6JnId
Who to follow
Tapan Ray
@tapan_ray
Experienced pharma professional and a blogger. Website: https://t.co/VKI8e6Tf11 My tweets are personal views and retweets are not endorsements.
Anju Ghangurde
@scripanjug
Executive Editor (Asia Pacific), Scrip/Pink Sheet, @Citeline @NorstellaCo but views own; believe in karma & that moms can move mountains
WBB Securities
@wbbsec
WBB Securities is a leading investment management, investment banking, and equity research firm focused primarily in the life science niche.
TwoFour Insight
@TwoFourInsight
about 10 years ago
Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group
#India
#pharma
https://t.co/TsGp7HAdBZ
TwoFour Insight
@TwoFourInsight
about 10 years ago
Newron
#Pharma
of
#Italy
Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group
#India
https://t.co/uV3Fy5wH25
TwoFour Insight
@TwoFourInsight
about 10 years ago
USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable -
#India
#pharma
TwoFour Insight Group https://t.co/nZC7RE7xFT
TwoFour Insight
@TwoFourInsight
about 10 years ago
Newron
#Pharma
of
#Italy
Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group
#India
https://t.co/6dAKUK5hZ9
TwoFour Insight
@TwoFourInsight
about 10 years ago
USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable -
#India
#pharma
TwoFour Insight Group https://t.co/oS1ZHutfC6
TwoFour Insight
@TwoFourInsight
about 10 years ago
Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group
#India
#pharma
https://t.co/SzrFHBTNt9
TwoFour Insight
@TwoFourInsight
about 10 years ago
Newron
#Pharma
of
#Italy
Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group
#India
https://t.co/bq20aUWczt
TwoFour Insight
@TwoFourInsight
about 10 years ago
USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable -
#India
#pharma
TwoFour Insight Group https://t.co/Mua9r9Ti2B
TwoFour Insight
@TwoFourInsight
about 10 years ago
Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group
#India
#pharma
https://t.co/XVQBBDHBZB
TwoFour Insight
@TwoFourInsight
about 10 years ago
Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in
#India
-
#pharma
https://t.co/5dTdDvOcwQ
TwoFour Insight
@TwoFourInsight
about 10 years ago
Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in
#India
-
#pharma
https://t.co/whIYSwrEVV
TwoFour Insight
@TwoFourInsight
about 10 years ago
Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in
#India
-
#pharma
https://t.co/b8TXZrb8lt
TwoFour Insight
@TwoFourInsight
about 10 years ago
India’s new patent policy spurs debate over implications for pharma https://t.co/8sjgLvl9AW via
@statnews
TwoFour Insight
@TwoFourInsight
about 10 years ago
USFDA Puts Yunnan Hande Bio-Tech on Import Alert - TwoFour Insight Group
#China
#pharma
https://t.co/MgD3oVzhbI
TwoFour Insight
@TwoFourInsight
about 10 years ago
Generic Crestor Market to Become Crowded in Near Future - TwoFour Insight Group
#India
#pharma
https://t.co/69IPecJmia
TwoFour Insight
@TwoFourInsight
about 10 years ago
Accord Receives ANDA Approval for Generic Treanda - TwoFour Insight Group
#India
#pharma
https://t.co/t9tpcFg5Fl
Last Seen Users on Sotwe
suka binor
Seen from
Indonesia
Kurtmehmet Eser
Seen from
Turkey
Boom Bang
Seen from
Thailand
Pentil coklat
Seen from
Indonesia
Kaio Rodrigues
Seen from
Brazil
Cirebla
evercenk
Seen from
Turkey
Pendekar Biru
Seen from
Indonesia
Kozelinekizvoli
Public_Sex
Seen from
Mexico
Trends for you
1
Balogun
Under 10K tweets
2
Belgium
Under 10K tweets
3
Country Roads
Under 10K tweets
4
Paul George
Under 10K tweets
5
#BringValkoBack
Under 10K tweets
6
#artfight
Under 10K tweets
7
Red Card
Under 10K tweets
8
UCMJ
Under 10K tweets
9
Walz
Under 10K tweets
10
Leavenworth
Under 10K tweets
Most Popular Users
1
Elon Musk
@elonmusk
240.6M followers
2
Barack Obama
@barackobama
119.2M followers
3
Donald J. Trump
@realdonaldtrump
111.7M followers
4
Cristiano Ronaldo
@cristiano
110.6M followers
5
Narendra Modi
@narendramodi
107M followers
6
Rihanna
@rihanna
97.7M followers
7
NASA
@nasa
92.2M followers
8
Justin Bieber
@justinbieber
90.9M followers
9
KATY PERRY
@katyperry
87.7M followers
10
Taylor Swift
@taylorswift13
81.5M followers
11
Lady Gaga
@ladygaga
73.1M followers
12
Virat Kohli
@imvkohli
69.9M followers
13
Kim Kardashian
@kimkardashian
69.8M followers
14
YouTube
@youtube
68.7M followers
15
Bill Gates
@billgates
63.9M followers
16
Neymar Jr
@neymarjr
62.7M followers
17
The Ellen Show
@theellenshow
62.4M followers
18
CNN
@cnn
61.9M followers
19
X
@x
60.8M followers
20
Selena Gomez
@selenagomez
60.8M followers
Olivia
Online
✨
⭐
💫